// // It is highly recommended to set this option, even though it's not required. // defaults to undefined. //appElement: "#page-container", // Optional. You can customize the name of the cookie that Orejime uses for storing // user consent decisions. // defaults to "orejime". cookieName: "diadao_cookies", // Optional. You can set a custom expiration time for the Orejime cookie, in days. // defaults to 365. cookieExpiresAfterDays: 365, // You must provide a link to your privacy policy page privacyPolicy: JSON.parse(Config.orejimePrivacyPolicyPage), // You must provide a link to your cookies policy page cookiePolicy: JSON.parse(Config.orejimeCookiesPage), // Optional. Applications configured below will be ON by default if default=true. // defaults to true default: true, // Optional. If "mustConsent" is set to true, Orejime will directly display the consent // manager modal and not allow the user to close it before having actively // consented or declined the use of third-party apps. // defaults to false mustConsent: false, // Optional. If "implicitConsent" is set to true, Orejime will automatically accept // cookies if the user continues his navigation on the website after the // first page. If you enable this, you must warn the user // of this behavior in the notice window. You can do that easily by overriding // translation strings (see below). // defaults to false implicitConsent: false, // Optional. You can define the UI language directly here. If undefined, Orejime will // use the value given in the global "lang" variable, or fallback to the value // in the lang attribute, or fallback to "en". lang: Config.currentLang, // You can overwrite existing translations and add translations for your // app descriptions and purposes. See `src/translations.yml` for a full // list of translations that can be overwritten // translations: Config.texts.orejime, // If you want to use custom text for your project translations: {}, // The list of third-party apps that Orejime will manage for you. // The apps will appear in the modal in the same order as defined here. // appsList: ["analytics", "big_calendar", "orejime", "offerhighlight"], appsList: JSON.parse(Config.orejimeAppsList), apps: [] }

全部新闻

讨论、会议及分享

网络研讨会和播客

Presentation of annual results for 2023 and ambitions for 2024

22 4 月 2024
Intrasense presents its 2023 annual results.Discover in this webinar the progress of Intrasense's medical imaging solutions, its 2024 objectives and ambitions.
观看视频

Presentation of the half-yearly financial results 2022

21 10 月 2022
To coincide with the publication of its half-year results for 2022, Intrasense will provide an update on its latest developments.
观看视频

Presentation of 2021 annual results and 2022 ambitions

14 3 月 2022
On the occasion of the publication of its 2021 annual results, Intrasense will provide an update on its latest developments.
观看视频

Demo of the new COVID-19 dedicated protocol

2 4 月 2020
This protocol offers numerous clinical advantages, particularly in terms of screening, pathological stage analysis and pathological progression.
观看视频
所有的网络研讨会

新闻稿

Intrasense presents its AI innovations at the SIRM congress in Italy

10 6 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces its participation in SIRM, the congress organized by the Italian Society of Medical and Interventional Radiology, to be held from June 20 to 23 in Milan (Italy).

发现更多

Intrasense announces CE certification of Liflow® to the new European regulation (MDR)

29 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, is proud to announce that the company has obtained CE certification under MDR (European Union Medical Device Regulation 2017/745), for the first version of its Liflow® solution.

发现更多

Intrasense announces the appointment of Jérôme Thiebaud as Chief Business Officer

24 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces the appointment of Jérôme Thiebaud as the Group's Chief Business Officer.

发现更多

Liflow®: an innovative AI-enhanced solution to optimize oncology follow-up

16 4 月 2024

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® and Liflow®, announces the regulatory submission of its Liflow® 1.0 solution (registered trademark of the Myra project), an oncology platform dedicated to the analysis of diagnostic imaging and cancer follow-up.

发现更多

Intrasense and Guerbet announce CE certification of Myrian 2.12, enhanced with Guerbet's prostate AI

8 4 月 2024

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and developer of Myrian®, and Guerbet (FR0000032526 GBT), world leader in medical imaging, are proud to announce that the Myrian® 2.12 platform has obtained CE certification under MDR, integrating prostate AI developed by Guerbet, the Veolity® LungCAD AI developed by MeVis Medical Solutions AG and the Icobrain™ AI developed by Icometrix. This market launch is a major step in the two companies' joint development plan and the realization of their growth ambitions.

发现更多
1 2 3 … 20
全部的新闻稿

我们的大会

SIRM 2024

From 06/20 to 06/23/2024
Allianz MiCo - Milan - Italy
发现更多

SERAM 2024

From 05/22 to 05/25/2024
International Convention Center - Barcelona - Spain
发现更多

RöKö 2024

From 08/05 to 10/05/2024
RheinMain CongressCenter - Wiesbaden - Germany
发现更多

ECR 2024

From 26/02 to 02/03/2024.
Exhibition Congress Center - Vienna - Austria
发现更多

RSNA 2023

From 05/22 to 05/25/2024
International Convention Center - Barcelona - Spain
发现更多

French days of radiology 2023

From 07/10 to 10/10/2022.
Congress Center - Paris - France
发现更多

AFIB Congress

From 28/09 to 30/09/2022 The Biomedical Engineers Congr […]
发现更多
我们所有的大会

博客或新闻

Disappearing artificial intelligence

At a time when everyone in medical imaging only talks a […]
阅读该文档

Brain perfusion CT, a key tool in the assessment of stroke

Stroke is a consequence of the obstruction or the ruptu […]
阅读该文档

Is teleradiology the future of radiology?

Teleradiology has evolved from a potential threat to a […]
阅读该文档
阅读所有新闻

想获得最新的消息吗

访问